Why Chlorhexidine Gluconate (CHG)-based Products Should Not Be Used on Open Wounds

WoundSource Page Designs_White Papers small

Why Chlorhexidine Gluconate (CHG)-based Products Should Not Be Used on Open Wounds

Country *

Job Title *

Work Setting *

Is CHG ever used in wounds in your facility? *

Does your facility have a standard protocol for wound cleansing? *

What products are in your cleansing protocol? *

Would you be interested in a Vashe protocol for your facility? *

By submitting your information through this form, you confirm that you agree to WoundSource's Privacy Policy , as well as sharing your information with any partners for marketing purposes. You can opt out at any time.

Chlorhexidine gluconate (CHG)–containing products are widely used for preoperative skin flora management, but many of these products have high concentrations of CHG that impair wound healing and should not be used on open wounds. Evidence shows that hypochlorous acid is safer than CHG for wound care.

This white paper sponsored by URGO Medical, maker of hypochlorous acid–preserved Vashe Wound Solution, reports the findings of six key publications that support concerns related to CHG cytotoxicity.

Wound care professionals faced with the vast array of available wound care products will appreciate this clear presentation of evidence extracted from the literature.

This white paper contains information on the following topics:

Mechanism of CHG cytotoxicity

CHG-induced inhibition of wound healing

Skin sensitivity to CHG

Safety of hypochlorous acid

Hypochlorous acid in biofilm disruption

Study comparing Vashe Wound Solution and CHG

Sponsored by URGO Medical North America